NTLA - Intellia Therapeutics Inc.

$11.71 as of 2026-10-07 · Healthcare · Biotechnology · Stock

NTLA (Intellia Therapeutics Inc.) is the #636 most-held security of 3,193 tracked on Upside Invest, held by 4 retail investors (1% of tracked portfolios), at an average allocation of 0.7% of their portfolio.

• Popularity rank: #636 of 3,193
• Holders on Upside: 4 retail investors
• Average allocation: 0.7%
• Average holder gain/loss: -12.9%
• Stock grade: D
• 30-day trading activity: 8 buys / 0 sells
• Market cap: $1.2B

Related Healthcare securities: LLY, UNH, JNJ, MRK, HIMS

Holder statistics come from anonymized brokerage portfolios connected to Upside Invest. Join to compare your portfolio, or explore all securities.